Pressure BioSciences Inc. (PBIO) Forms Strategic Collaboration with Phasex Corporation to Address Markets for Nanoemulsions
Goal is to combine PBIO’s patented Ultra Shear Technology (UST) with Phasex’ Supercritical Fluid (SCF) processing to develop stable, water-soluble nanoemulsions As part of this collaboration, PBIO and Phasex seek to develop stable, water-soluble nanoemulsions of nutraceuticals, including CBD-enriched plant oil CEO of PBIO sees collaboration leading to a ‘Value-add’ for Phasex customers and a highly profitable service model for both PBIO and Phasex Pressure BioSciences Inc. (OTCQB: PBIO) recently announced a strategic collaboration with Phasex Corporation to develop stable, water-soluble nanoemulsions of nutraceuticals (http://nnw.fm/RhwT6). These nanoemulsions may exhibit improved absorption, greater stability, higher bioavailability and other strategic and medical…







